These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Binding and catalysis: a thermodynamic study on a catalytic antibody system. Wade H; Scanlan TS Chembiochem; 2003 Jun; 4(6):537-40. PubMed ID: 12794866 [No Abstract] [Full Text] [Related]
4. Computer-aided rational design of catalytic antibodies: The 1F7 case. Martí S; Andrés J; Silla E; Moliner V; Tuñón I; Bertrán J Angew Chem Int Ed Engl; 2007; 46(1-2):286-90. PubMed ID: 17124715 [No Abstract] [Full Text] [Related]
5. Improving GPX activity of selenium-containing human single-chain Fv antibody by site-directed mutation based on the structural analysis. Xu J; Song J; Yan F; Chu H; Luo J; Zhao Y; Cheng X; Luo G; Zheng Q; Wei J J Mol Recognit; 2009; 22(4):293-300. PubMed ID: 19277948 [TBL] [Abstract][Full Text] [Related]
6. Alchemy, enzymes, and the blind-watchmaker. Barbas CF; List B Nat Biotechnol; 1998 May; 16(5):423-4. PubMed ID: 9592389 [No Abstract] [Full Text] [Related]
8. The therapeutic potential for catalytic antibodies: from a concept to a promise. Jones LH; Wentworth P Mini Rev Med Chem; 2001 Jul; 1(2):125-32. PubMed ID: 12369978 [TBL] [Abstract][Full Text] [Related]
9. [Catalytic antibody-structure and possible applications]. Amital H; Tur-Caspa I; Hendler I; Shoenfeld Y Harefuah; 1995 Mar; 128(5):295-8. PubMed ID: 7744352 [No Abstract] [Full Text] [Related]
10. Positional ordering of reacting groups contributes significantly to the efficiency of proton transfer at an antibody active site. Seebeck FP; Hilvert D J Am Chem Soc; 2005 Feb; 127(4):1307-12. PubMed ID: 15669871 [TBL] [Abstract][Full Text] [Related]
11. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis. Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500 [TBL] [Abstract][Full Text] [Related]
13. A modelling study of a non-concerted hydrolytic cycloaddition reaction by the catalytic antibody H11. Clark RL; Johnston BF; Suckling CJ; Mackay SP Bioorg Med Chem; 2006 Apr; 14(8):2674-83. PubMed ID: 16378728 [TBL] [Abstract][Full Text] [Related]
14. Reaction properties of catalytic antibodies encapsulated in organo substituted SiO2 sol-gel materials. Kato K; Saito T; Seelan S; Tomita M; Yokogawa Y J Biosci Bioeng; 2005 Oct; 100(4):478-80. PubMed ID: 16310742 [TBL] [Abstract][Full Text] [Related]
15. Catalytic antibodies and other biomimetic catalysts. Stevenson JD; Thomas NR Nat Prod Rep; 2000 Dec; 17(6):535-77. PubMed ID: 11152421 [No Abstract] [Full Text] [Related]
16. Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies. Johnson G; Moore SW J Mol Recognit; 2009; 22(3):188-96. PubMed ID: 19051205 [TBL] [Abstract][Full Text] [Related]
17. Selection and characterization of lipase abzyme from phage displayed antibody libraries. Leong MK; Chen C; Shar KC; Shiuan D Biochem Biophys Res Commun; 2007 Sep; 361(3):567-73. PubMed ID: 17673171 [TBL] [Abstract][Full Text] [Related]